Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation. - Wikidata - wikimedia - TriplyDB

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

http://www.wikidata.org/entity/Q41944335

about

Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn.Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytes Decreased Srcasm expression in hyperproliferative cutaneous lesions From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis.Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.Mouse Fyn induces pseudopodium formation in Chinese hamster ovary cells.Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion.Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2.Focal adhesion kinase and Src expression in premalignant and malignant skin lesions.FYNagling divergent adhesive functions for Fyn in keratinocytes.

P2860

Q26745755-FCFBD6DA-B7F4-4D5C-8DAA-F1D249196E19 Q28235184-03D8698A-2E49-4604-9668-F1ED85A7FA4C Q30578448-2C8AD127-19FF-48B7-8680-8BE9416A2CB9 Q34997018-15400176-541D-47F4-A922-25A5C52B50E3 Q34997036-74F570B2-0AC1-4CF9-904B-681C2B5FE7E1 Q35698913-FB8A714F-7D82-4B7C-9080-00681B32F159 Q37026588-622ECB9C-D6C8-4B1E-92F6-EB71B00D84C6 Q37480072-E22279E3-C737-45D5-83B4-20E0F47E834A Q37681074-BD3DE2B0-33C0-46A4-9AB2-3095CA8BDBE2 Q38979793-6824A918-43C1-4E59-9FF4-A6653C964C89 Q41868155-95222832-877E-4637-8291-D5645327C8CE Q42737351-FE381B8F-B8CD-48C7-95B2-E9D9C91A7A10 Q47098074-EFB3FEAF-EEE3-45E9-818A-5EA0D61D42D5 Q53223362-CAD09CA6-16E9-43E2-B3BE-38881B53F8BD Q54341168-42B3CF30-9F34-4D4F-A5B0-1F6E0B5C7117

P2860

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

http://www.wikidata.org/entity/Q41944335

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

@en

type

label

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

@en

prefLabel

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

@en

P1433

Q41944335-702BF3DA-95CB-4E12-91D4-3EA2C1F74843

P1476

Q41944335-FDCDA616-5A83-4810-8810-3CA652A89B06

P2093

Q41944335-08E5454B-9302-402B-8525-8E9C7EBCCFC8

Q41944335-35C34D6E-F07B-494B-A3D7-D1CE0B60D11E

Q41944335-9C6D0CF7-880F-4C74-A7CA-85BA46C4A3DF

Q41944335-ACD9061B-068B-4390-BFCB-4B65B83AC822

P2860

Q41944335-01AF88FE-AAE5-4165-BBBC-BE41792A0AC5

Q41944335-04D1B148-B9AF-4AC7-AB1B-8BC4D5664030

Q41944335-09454048-BA1C-411A-B9FB-EC50353B5877

Q41944335-0A2C54C6-925E-473A-ACAD-AC0A8EF96FB9

Q41944335-16A2B053-4CD8-42C3-B19A-CB0B61FB9C5E

Q41944335-16C3960E-4AEA-46A4-94DF-47B50E54DC44

Q41944335-1C78B7E6-0C53-45B3-837E-FB4E2A9B34AE

Q41944335-1EAE49C7-F4F7-4EAD-8B43-D0A59D10FEE0

Q41944335-2011130D-A913-44C1-AAE6-C7678323C1A3

Q41944335-23A34BFA-B390-440C-BB0E-7F78316034F7

P304

Q41944335-9C71B29E-E75E-4E90-B637-91F6A0A659F9

P31

Q41944335-43F0427A-2FCE-461E-8E6F-FE985500E6DF

P356

Q41944335-C9CEA053-E4C8-416F-9283-E610908567F2

P407

Q41944335-F3F58A62-AA2F-4D88-B56D-F07D753C865B

P433

Q41944335-13DEEB19-648B-441E-8F1B-6AF30074CDE0

P478

Q41944335-3BC482AB-35A9-4D10-9D23-A63AA67DE245

P50

Q41944335-11B01702-BF33-429E-907B-2841C82FE936

P577

Q41944335-4D979FBD-55C4-4A22-9F94-F1770598C353

P5875

Q41944335-9DFB46E7-A6B0-4894-A3C7-D20B4388C82A

P698

Q41944335-7C9267EF-8989-4BAC-B09C-30273A55550A

P932

Q41944335-EF7E1E8C-519F-4800-9DBA-0B6CF2FE2114

P356

P1433

Journal of Biological Chemistry

P1476

Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation

@en

P2093

Christine Marshall

http://www.w3.org/2001/XMLSchema#string

John T Seykora

http://www.w3.org/2001/XMLSchema#string

Lijuan Mei

http://www.w3.org/2001/XMLSchema#string

Weijie Li

http://www.w3.org/2001/XMLSchema#string

P2860

Tom1, a VHS domain-containing protein, interacts with tollip, ubiquitin, and clathrin

Interactions of TOM1L1 with the multivesicular body sorting machinery

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.

Oncogenic kinase signalling

Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes

'Srcasm: a novel Src activating and signaling molecule

Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit

Cellular functions regulated by Src family kinases

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

P304

1161-1169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M606583200

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6748553

http://www.w3.org/2001/XMLSchema#string

P698

17046829

http://www.w3.org/2001/XMLSchema#string

P932

3099404

http://www.w3.org/2001/XMLSchema#string